Search results
Found 10535 matches for
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
LungVax
LungVax: A Phase I Dose-escalation and Phase II Precision-Prevention trial of ChAdOx2-lungvax-NYESO vaccination for patients at risk of new or recurrent non-small cell lung cancer (NSCLC
Advancing CLL Management
This is a continuing professional development course promoting state of the art Chronic Lymphocytic Leukaemia diagnosis, management, and clinical research globally. This course is run in partnership with the International Workshop on Chronic Lymphocytic Leukemia (iwCLL).